After signing up, you'll start to receive regular news updates from us.
Chembio's DPP® International Patent Protection Expanding
Complete the form below to unlock access to ALL audio articles.
Chembio Diagnostics, Inc. has reported that its Dual Path Platform (DPP®) technology has been or will soon be granted patent protection in a number of major markets including Japan, with the Company recently being notified that the DPP® patent has been allowed in Japan and will therefore be issued there shortly.
The anticipated issuance in Japan, combined with previous DPP® patent issuances in the United States in 2007, and in the United Kingdom, China, Indonesia, Singapore, Malaysia, Australia, Eurasia, and Mexico more recently provides Chembio with an increasingly global patent protection for DPP® products covering many large and emerging markets.
Chembio believes this is important in connection with possible collaborations, distribution agreements, and/or other commercial or strategic transactions, as well as to investors.
Furthermore, to the extent DPP® patent applications pending in Europe, South America, Korea, and other jurisdictions result in additional patent DPP® issuances to Chembio, the global footprint of this patent protection would be even further extended.
Javan Esfandiari, Chembio's Senior Vice President of R&D and the inventor of the DPP® technology, commented, "I am very pleased about the progress in expanding our DPP® intellectual property protection, and I am appreciative of the hard work of our R&D team and the overall commitment by Chembio to the development of products that incorporate our DPP® technology."
